pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,854 catalysts · 18,987 approval · 5,811 phase readout · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 14 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 11 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 14 catalysts2026-11-04: 21 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: recall×type: grant×clear all
type
  • approval18,987
  • phase readout5,811
  • device 510k5,000
  • grant4,728
  • 8k filing2,984
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings573
  • therapy area

    no tagged catalysts yet

    Week of Dec 15, 2025

    8
    ›Dec 19, 2025grant234d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — Examining the role of locus coeruleus glucagon-like peptide-1 receptors infee...Xeris Biopharma Holdings, Inc.

    DK grant. $150,930. PI: Samantha Fortin

    full page →nih reporter ↗
    ›Dec 19, 2025grant234d agoUNIVERSITY OF WASHINGTON — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - TASK AREA AUniversity of Washington

    HL grant. $3,202,749. PI: Robyn Leagh McClelland

    full page →nih reporter ↗
    ›Dec 19, 2025grant234d agoUNIVERSITY OF CALIFORNIA BERKELEY — Leveraging Adaptive Evolution and High-Throughput Techniques to Dissect the L...

    OD grant. $802,500. PI: Margaux Pinney

    full page →nih reporter ↗
    ›Dec 19, 2025grant234d agoNORTHWESTERN UNIVERSITY AT CHICAGO — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTERNorthwestern University

    HL grant. $829,413. PI: NORRINA Bai ALLEN

    full page →nih reporter ↗
    ›Dec 19, 2025grant234d agoJOHNS HOPKINS UNIVERSITY — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)Johns Hopkins University

    HL grant. $697,200. PI: WENDY S POST

    full page →nih reporter ↗
    ›Dec 19, 2025grant234d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC), TASK AREA AUniversity of California Los Angeles

    HL grant. $674,872. PI: KAROL E WATSON

    full page →nih reporter ↗
    ›Dec 19, 2025grant234d agoWAKE FOREST UNIVERSITY HEALTH SCIENCES — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER, TASK AREA AWake Forest University

    HL grant. $505,956. PI: Alain Gerald Bertoni

    full page →nih reporter ↗
    ›Dec 19, 2025grant234d agoGEORGE WASHINGTON UNIVERSITY — AIDS and Cancer Specimen Resource (ACSR)

    CA grant. $897,500. PI: Jeffrey Michael Bethony

    full page →nih reporter ↗

    Week of Dec 22, 2025

    17
    ›Dec 22, 2025grant231d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Integrative Predictors of Temporomandibular Degenerative Joint Disease

    DE grant. $698,865. PI: Lucia H Cevidanes

    full page →nih reporter ↗
    ›Dec 22, 2025grant

    Week of Dec 29, 2025

    25
    ›Dec 29, 2025grant224d agoDARTMOUTH-HITCHCOCK CLINIC — Improving utilization of guideline directed medical therapy and structured ex...

    GM grant. $132,000. PI: Rebecca E Scully

    full page →nih reporter ↗
    ›Dec 30, 2025grant
    ← prev
    page 68 of 118
    next →
    231d ago
    EMORY UNIVERSITY — Critical Care Training ProgramEmory University

    GM grant. $3,000. PI: Craig M Coopersmith

    full page →nih reporter ↗
    ›Dec 22, 2025grant231d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Systems Genetics of Vascular Smooth Muscle PhenotypesUniversity of California Los Angeles

    HL grant. $522,130. PI: Mete Civelek

    full page →nih reporter ↗
    ›Dec 22, 2025grant231d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Integrating Multi-Omics to Uncover Shared Mechanisms Linking Physical Frailty...

    AG grant. $49,438. PI: Jiachen Chen

    full page →nih reporter ↗
    ›Dec 24, 2025recall229d agoGolden State Medical Supply Inc. recall (Cls II)Beximco Pharmaceuticals USA Inc

    Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10 — Reason: Presence of Foreign Tablets/Capsules — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoSUN PHARMA /TARO recall (Cls II)ATLAS Molecular Pharma SL

    Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08 — Reason: Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoSOMERSET THERAPEUTICS LLC recall (Cls III)Somerset Therapeutics LLC

    Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01. — Reason: Subpotent product:out of specification assay results observed during long term stability testing. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoNovocol Pharmaceutical of Canada, Inc. recall (Cls II)

    Benco dental Graham CHEMICAL CO., Mepivacaine HCI 3% (30 mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Distributed by Benco Dental 295 Center Point Blvd, Pittston, PA 18640, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66975-406-51. — Reason: Defective container: cracked/broken cartridges — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoPreferred Pharmaceuticals, Inc. recall (Cls II)InMed Pharmaceuticals Inc.

    Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01 — Reason: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoNovocol Pharmaceutical of Canada, Inc. recall (Cls II)

    darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66467-9760-5. — Reason: Defective container: cracked/broken cartridges — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoNovocol Pharmaceutical of Canada, Inc. recall (Cls II)DENTSPLY Pharmaceutical

    3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16. — Reason: Defective container: cracked/broken cartridges — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoSOMERSET THERAPEUTICS LLC recall (Cls III)Somerset Therapeutics LLC

    Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10. — Reason: Subpotent product:out of specification assay results observed during long term stability testing. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoNovocol Pharmaceutical of Canada, Inc. recall (Cls II)DENTSPLY Pharmaceutical

    2% Xylocaine DENTAL with Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose cartridges, 1.7 mL each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-176-16. — Reason: Defective container: cracked/broken cartridges — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoNovocol Pharmaceutical of Canada, Inc. recall (Cls II)Opus Genetics, Inc.

    OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10 — Reason: Defective container: cracked/broken cartridges — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoSOMERSET THERAPEUTICS LLC recall (Cls III)Somerset Therapeutics LLC

    Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10. — Reason: Subpotent product:out of specification assay results observed during long term stability testing. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoNovocol Pharmaceutical of Canada, Inc. recall (Cls II)Fresenius Kabi USA LLC

    Cook-Walte, Carbocaine 3% (30 mg/mL), (mepivacaine hydrochloride Injection, USP), packaged in a carton containing 50 Single-Dose Cartridges, 1.7 mL, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 0362-0753-05. — Reason: Defective container: cracked/broken cartridges — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 24, 2025recall229d agoNovocol Pharmaceutical of Canada, Inc. recall (Cls II)International Medication Systems Ltd

    Lidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Patterson Dental Supply, Inc., 1031 Mendota Heights Road, Saint Paul, MN55120, Manufactured by: Novocol Pharmaceutical of Canada, Inc., NDC 50227-1030-5. — Reason: Defective container: cracked/broken cartridges — Status: Ongoing

    full page →fda recalls ↗
    223d ago
    RESEARCH INST NATIONWIDE CHILDREN'S HOSP — Somatic mutations in autism spectrum disorder

    MH grant. $181,224. PI: ALISA MO

    full page →nih reporter ↗
    ›Dec 31, 2025recall222d agoMerck Sharp & Dohme LLC recall (Cls II)Merck Sharp & Dohme LLC

    Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03 — Reason: Presence of particulate matter: potential presence of metal particulates in the product. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 31, 2025recall222d agoMerck Sharp & Dohme LLC recall (Cls II)Merck Sharp & Dohme LLC

    Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02. — Reason: Presence of particulate matter: potential presence of metal particulates in the product. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 31, 2025grant222d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Cerebral blood flow resistance mapping to identify amyloid-related imaging ab...

    AG grant. $75,520. PI: Wesley T Richerson

    full page →nih reporter ↗
    ›Dec 31, 2025grant222d agoUNIVERSITY OF WASHINGTON — Understanding the mechanisms driving emergence of atypical age-associated thy...University of Washington

    AG grant. $49,538. PI: Dante Dennis Verendia Acenas II

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Morphogen signaling feedback and dynamics in embryonic patterning

    HD grant. $49,538. PI: Alison Guyer

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Proteomic determinants of response to checkpoint blockade in malignant pleura...University of California Los Angeles

    CA grant. $407,412. PI: Bryan Michael Burt

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoVETERANS HEALTH ADMINISTRATION — Precision-Medicine Diagnostic Support in Hospitalized Veterans with Acute Kid...

    VA grant. PI: MICHAEL E. MATHENY

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoHARVARD MEDICAL SCHOOL — Forebrain Representations and Control of Sniffing

    DC grant. $82,540. PI: Byron Howard Price

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoNORTHWESTERN UNIVERSITY AT CHICAGO — DISE - A universal kill code in health and diseaseNorthwestern University

    AG grant. $457,112. PI: Marcus E. Peter

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoUNIVERSITY OF SOUTHERN CALIFORNIA — Multiscale Modeling of Hippocampus Vulnerability to Alzheimer's Disease Neuro...University of Southern California

    AG grant. $695,789. PI: Michael Bienkowski

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoUNIVERSITY OF TEXAS AT AUSTIN — CFTR gene correction via targeted exon replacement

    HL grant. $41,057. PI: Jesse Buffington

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Network biomarkers for early detection of cognitive impairment using digital ...

    AG grant. $323,825. PI: Shariq Mohammed

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoUNIVERSITY OF CALIFORNIA AT DAVIS — Taste perception of host cues in the invasive disease vector mosquito Aedes a...

    DC grant. $238,502. PI: Lisa Soyeon Baik

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoPENNSYLVANIA STATE UNIVERSITY, THE — Estimation of risk associated with zoonotic tuberculosis in South India

    AI grant. $85,563. PI: Vivek Kapur

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoIOWA CITY VA MEDICAL CENTER — Development of Automated Motility and Strabismus Evaluation for diagnosis and...

    VA grant. PI: Alina Valentina Dumitrescu

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoVA BOSTON HEALTH CARE SYSTEM — The Role of Annexin A1 Expression in Glioblastoma-Associated Astrocytes

    VA grant. PI: Brian Magne Andersen

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoVETERANS AFFAIRS MED CTR SAN FRANCISCO — The Effects of Orexin Antagonism on Fear Extinction in PTSD

    VA grant. PI: SABRA INSLICHT

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoUNIVERSITY OF FLORIDA — Identifying Translational Measures of Osteoarthritic Pain Between Preclinical...University of Florida

    AR grant. $44,466. PI: Kaitlin Southern

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoUNIVERSITY OF ROCHESTER — Selective vulnerability of fronto-insular network in aging and Alzheimer's di...University of Rochester

    AG grant. $656,829. PI: Kuan Hong Wang

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoAUGUSTA UNIVERSITY — Epigenetic mechanisms of selective vulnerability of entorhinal PV neurons in ...

    AG grant. $542,699. PI: Yun Lei

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoOHIO STATE UNIVERSITY — Uncovering the role of WFS1 deficiency in selective vulnerability in Alzheime...

    AG grant. $657,000. PI: Hongjun Fu

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoUNIVERSITY OF FLORIDA — Elucidating the effects of sublingual tablets containing buprenorphine on den...University of Florida

    DE grant. $47,454. PI: Kyle Vrej Kasparian

    full page →nih reporter ↗
    ›Jan 1, 2026grant221d agoOSU CENTER FOR HEALTH SCIENCES — Cumulative Effect of ACEs on the Neurocircuitry of Drug Withdrawal

    GM grant. $208,403. PI: Jason A. Avery

    full page →nih reporter ↗
    $XERS7.9300+7.74%
    $IRD2.9200-4.26%
    $INM1.4700+2.80%